Zolgensma ‘Saved All of Our Lives’: A Family’s Journey Through Gene Therapy
Tina and Torence Anderson’s sixth and youngest child, Malachi, came into the world on July 31, 2015.
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Tina and Torence Anderson’s sixth and youngest child, Malachi, came into the world on July 31, 2015.
A child who barely moved in the womb in the final months before his birth and then had multiple bone…
Destiny McCalvin gave birth to her second child, a girl she named Kenzlee, after what she and her doctors took…
Treating adults with spinal muscular atrophy (SMA) with Spinraza (nusinersen) was safe and improved their muscle strength,…
Spinal muscular atrophy (SMA) treatment with Biogen’s Spinraza (nusinersen) has resulted in motor milestone achievements in line with normal…
Learning that spinal muscle atrophy was the reason her 15-month-old son couldn’t do what others his age could was a…
A video game called ACTIVE could be used to monitor changes in motor function in people with spinal muscular atrophy (SMA) types…
Spinal muscular atrophy (SMA) patients transitioning from pediatric to adult care face unmet health needs and possible barriers to…
Through extensive experiments in cell and animal models of spinal muscular atrophy (SMA), investigators have demonstrated the possible usefulness of…
Early intervention is crucial for the successful management of spinal muscular atrophy (SMA), according to the authors of a…
Get regular updates to your inbox.